Literature DB >> 3251560

Overlap between P300 and movement-related-potentials: a response to Verleger.

A Kok1.   

Abstract

In reply to Verleger's commentary, I first clarify what the term "MRP overlap" implies; by means of a simple additive simulation it is shown that overlap between a stable P300 and a MRP that moves in time with reaction-time, may cause two types of artefacts--amplitude reduction and double peaking of P300. Following Verleger's suggestion, it is then argued that the effects of stimulus-degradation on P300 amplitude in our experiments was, at least in part, due to overlap with negative components of the MRP (in the go-intact condition), and with positive CNV return (in the nogo-intact condition). It is concluded that MRP overlap is not only an artefact but also a useful index of motor-preparation in reaction tasks, and that more refined methods should be developed in future research for accurate estimation of MRP overlap in stimulus-locked ERP waveforms.

Entities:  

Mesh:

Year:  1988        PMID: 3251560     DOI: 10.1016/0301-0511(88)90005-1

Source DB:  PubMed          Journal:  Biol Psychol        ISSN: 0301-0511            Impact factor:   3.251


  12 in total

1.  Button-pressing affects P300 amplitude and scalp topography.

Authors:  D F Salisbury; B Rutherford; M E Shenton; R W McCarley
Journal:  Clin Neurophysiol       Date:  2001-09       Impact factor: 3.708

2.  The NoGo P300 'anteriorization' effect and response inhibition.

Authors:  Dean F Salisbury; Carlye B Griggs; Martha E Shenton; Robert W McCarley
Journal:  Clin Neurophysiol       Date:  2004-07       Impact factor: 3.708

3.  The influence of perceptual and semantic categorization on inhibitory processing as measured by the N2-P3 response.

Authors:  Mandy J Maguire; Matthew R Brier; Patricia S Moore; Thomas C Ferree; Dylan Ray; Stewart Mostofsky; John Hart; Michael A Kraut
Journal:  Brain Cogn       Date:  2009-09-20       Impact factor: 2.310

4.  Influence of comorbid obsessive-compulsive symptoms on brain event-related potentials in Gilles de la Tourette syndrome.

Authors:  Geneviève Thibault; Mihaela Felezeu; Kieron P O'Connor; Christo Todorov; Emmanuel Stip; Marc E Lavoie
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-02-14       Impact factor: 5.067

5.  Different timing features in brain processing of core and moral disgust pictures: an event-related potentials study.

Authors:  Xiangyi Zhang; Qi Guo; Youxue Zhang; Liandi Lou; Daoqun Ding
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

6.  The Impact of a Cognitive-Behavioral Therapy on Event-Related Potentials in Patients with Tic Disorders or Body-Focused Repetitive Behaviors.

Authors:  Simon Morand-Beaulieu; Kieron P O'Connor; Maxime Richard; Geneviève Sauvé; Julie B Leclerc; Pierre J Blanchet; Marc E Lavoie
Journal:  Front Psychiatry       Date:  2016-05-10       Impact factor: 4.157

7.  A no-go related prefrontal negativity larger to irrelevant stimuli that are difficult to suppress.

Authors:  Alice M Proverbio; Marzia Del Zotto; Nicola Crotti; Alberto Zani
Journal:  Behav Brain Funct       Date:  2009-06-25       Impact factor: 3.759

Review 8.  Annual research review: Reaction time variability in ADHD and autism spectrum disorders: measurement and mechanisms of a proposed trans-diagnostic phenotype.

Authors:  Sarah L Karalunas; Hilde M Geurts; Kerstin Konrad; Stephan Bender; Joel T Nigg
Journal:  J Child Psychol Psychiatry       Date:  2014-03-13       Impact factor: 8.982

9.  Negative mood state enhances the susceptibility to unpleasant events: neural correlates from a music-primed emotion classification task.

Authors:  Jiajin Yuan; Jie Chen; Jiemin Yang; Enxia Ju; Greg J Norman; Nanxiang Ding
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

10.  Revealing time-unlocked brain activity from MEG measurements by common waveform estimation.

Authors:  Yusuke Takeda; Kentaro Yamanaka; Noriko Yamagishi; Masa-aki Sato
Journal:  PLoS One       Date:  2014-05-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.